Tapewire

Nasdaq · USD

RCEL

AVITA Medical, Inc.

Export transactions ↓
Tapewire entity
5905
SEC CIK
0001762303
Parsed reports
140

Last 12 months

Inside the activity.

14 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202610
Mar 202610
Apr 202600
May 202620
Jun 2026100
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 01, 2022 Filed Jul 6, 2022 22:57 UTC
Holder MichaelChief Financial Officer
GrantStock Options (Right to Buy) · Derivative 20,650 $0.00 Strike: $4.97 $0.00
Disclosure

SEC source: 0001209191-22-041378 · doc4.xml · derivative · entry 2

Holder Michael · CIK 0001515140 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,650

Underlying: Common Stock · 20,650 shares

Expires 2032-07-01

F3 · derivative.exercise_date: These Stock Options vest in four equal annual installments beginning on August 20, 2023.

Read SEC document
July 01, 2022 Filed Jul 6, 2022 22:57 UTC
Holder MichaelChief Financial Officer
GrantCommon Stock 35,950 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-041378 · doc4.xml · nonDerivative · entry 1

Holder Michael · CIK 0001515140 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,450

F1 · price: Reflects Restricted Stock Units, each representing a contingent right to be issued one share of Common Stock. These Restricted Stock Units vest in four equal annual installments beginning on August 20, 2023.

F2 · balance_after: Includes unvested Restricted Stock Units.

Read SEC document
July 01, 2022 Filed Jul 6, 2022 22:55 UTC
McGee Kathy M.Chief Operating Officer
GrantStock Options (Right to Buy) · Derivative 20,650 $0.00 Strike: $4.97 $0.00
Disclosure

SEC source: 0001209191-22-041376 · doc4.xml · derivative · entry 2

McGee Kathy M. · CIK 0001835186 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,650

Underlying: Common Stock · 20,650 shares

Expires 2032-07-01

F3 · derivative.exercise_date: These Stock Options vest in four equal annual installments beginning on August 20, 2023.

Read SEC document
July 01, 2022 Filed Jul 6, 2022 22:55 UTC
McGee Kathy M.Chief Operating Officer
GrantCommon Stock 35,950 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-041376 · doc4.xml · nonDerivative · entry 1

McGee Kathy M. · CIK 0001835186 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,450

F1 · price: Reflects Restricted Stock Units, each representing a contingent right to be issued one share of Common Stock. These Restricted Stock Units vest in four equal annual installments beginning on August 20, 2023.

F2 · balance_after: Includes unvested Restricted Stock Units.

Read SEC document
June 01, 2022 Filed Jun 2, 2022 21:01 UTC
PERRY MICHAEL SDirector · Chief Executive Officer
OtherCommon Stock 23,754 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-033585 · doc4.xml · nonDerivative · entry 1

PERRY MICHAEL S · CIK 0001250379 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 297,958

F1 · kind: These shares of Common Stock represent half of the shares of Common Stock that were issued upon the vesting of Restricted Stock Units ("RSUs") that were previously included in the amount of shares of Common Stock beneficially owned by the Reporting Person. Upon vesting of the RSUs, these shares of Common Stock were transferred to the Reporting Person's former spouse pursuant to a property settlement agreement.

F2 · balance_after: Includes 71,440 unvested RSUs with vesting conditions based on the Reporting Person's continued employment or the market price of the Issuer's common stock. Pursuant to a property settlement agreement, half of the shares of Common Stock underlying such RSUs will be transferred to the Reporting Person's former spouse upon the respective vesting events.

F3 · balance_after: Includes 634,602 of the Issuer's CHESS Depositary Interests ("CDIs"). CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the "ASX") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of Common Stock and have all the rights and privileges of Common Stock. The Reporting Person holds 634,602 CDIs, which translate into 126,920 of the shares of Common Stock set forth above.

Read SEC document
February 24, 2022 Filed Feb 25, 2022 21:54 UTC
PERRY MICHAEL SDirector · Chief Executive Officer
SaleCommon Stock 10,812 $8.74 $94,496.88
Disclosure

SEC source: 0001209191-22-013222 · doc4.xml · nonDerivative · entry 3

PERRY MICHAEL S · CIK 0001250379 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 321,712

F5 · kind: Represents shares sold in order to pay withholding taxes due in connection with the vesting of RSUs.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.42 to $8.96. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of the shares of Common Stock sold at each separate price within the ranges set forth in this footnote to this Form 4.

F2 · balance_after: Includes unvested RSUs with vesting conditions based on the Reporting Person's continued employment or the market price of the Issuer's common stock.

F3 · balance_after: Includes 634,602 of the Issuer's CHESS Depositary Interests ("CDIs"). CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the "ASX") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of Common Stock and have all the rights and privileges of Common Stock. The Reporting Person holds 634,602 CDIs, which translate into 126,920 of the shares of Common Stock set forth above.

Read SEC document
February 23, 2022 Filed Feb 25, 2022 21:54 UTC
PERRY MICHAEL SDirector · Chief Executive Officer
GrantStock Options (Right to Buy) · Derivative 3,450 $0.00 Strike: $12.18 $0.00
Disclosure

SEC source: 0001209191-22-013222 · doc4.xml · derivative · entry 4

PERRY MICHAEL S · CIK 0001250379 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,450

Underlying: Common Stock · 3,450 shares

Expires 2031-12-22

F7 · kind: These Stock Options were originally granted on December 22, 2021 and vested on February 23, 2022 in connection with the satisfaction of a performance-based vesting condition.

Read SEC document
February 23, 2022 Filed Feb 25, 2022 21:54 UTC
PERRY MICHAEL SDirector · Chief Executive Officer
GrantCommon Stock 5,960 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-013222 · doc4.xml · nonDerivative · entry 2

PERRY MICHAEL S · CIK 0001250379 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 332,524

F4 · kind: These shares of Common Stock were issued upon the vesting of RSUs, which were originally granted on December 22, 2021, in connection with the satisfaction of a performance-based vesting condition.

F2 · balance_after: Includes unvested RSUs with vesting conditions based on the Reporting Person's continued employment or the market price of the Issuer's common stock.

F3 · balance_after: Includes 634,602 of the Issuer's CHESS Depositary Interests ("CDIs"). CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the "ASX") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of Common Stock and have all the rights and privileges of Common Stock. The Reporting Person holds 634,602 CDIs, which translate into 126,920 of the shares of Common Stock set forth above.

Read SEC document
February 23, 2022 Filed Feb 25, 2022 21:54 UTC
PERRY MICHAEL SDirector · Chief Executive Officer
GrantCommon Stock 23,753 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-013222 · doc4.xml · nonDerivative · entry 1

PERRY MICHAEL S · CIK 0001250379 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 326,564

F1 · kind: These shares of Common Stock were issued upon the vesting of Restricted Stock Units ("RSUs"), which were originally granted on November 26, 2019, in connection with the satisfaction of a performance-based vesting condition.

F2 · balance_after: Includes unvested RSUs with vesting conditions based on the Reporting Person's continued employment or the market price of the Issuer's common stock.

F3 · balance_after: Includes 634,602 of the Issuer's CHESS Depositary Interests ("CDIs"). CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the "ASX") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of Common Stock and have all the rights and privileges of Common Stock. The Reporting Person holds 634,602 CDIs, which translate into 126,920 of the shares of Common Stock set forth above.

Read SEC document
December 22, 2021 Filed Dec 27, 2021 21:30 UTC GrantStock Options (Right to Buy) · Derivative 2,550 $0.00 Strike: $12.18 $0.00
Disclosure

SEC source: 0001209191-21-071250 · doc4.xml · derivative · entry 4

REED JAN STERN · CIK 0001124181 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,550

Underlying: Common Stock · 2,550 shares

Expires 2031-12-22

F5 · derivative.exercise_date: These Stock Options vest on the date 12 months following the grant date.

Read SEC document
December 22, 2021 Filed Dec 27, 2021 21:30 UTC GrantStock Options (Right to Buy) · Derivative 4,925 $0.00 Strike: $12.18 $0.00
Disclosure

SEC source: 0001209191-21-071250 · doc4.xml · derivative · entry 3

REED JAN STERN · CIK 0001124181 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,925

Underlying: Common Stock · 4,925 shares

Expires 2031-12-22

F4 · derivative.exercise_date: These Stock Options vest in three equal annual installments on the first, second and third anniversaries of the grant date.

Read SEC document
December 22, 2021 Filed Dec 27, 2021 21:30 UTC GrantCommon Stock 4,350 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-071250 · doc4.xml · nonDerivative · entry 2

REED JAN STERN · CIK 0001124181 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,025

F3 · price: Represents an award of RSUs that vest on the date 12 months following the grant date.

F2 · balance_after: Includes unvested RSUs.

Read SEC document
December 22, 2021 Filed Dec 27, 2021 21:30 UTC GrantCommon Stock 8,675 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-071250 · doc4.xml · nonDerivative · entry 1

REED JAN STERN · CIK 0001124181 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,675

F1 · price: Represents an award of Restricted Stock Units ("RSUs"), each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs vest in three equal annual installments on the first, second and third anniversaries of the grant date.

F2 · balance_after: Includes unvested RSUs.

Read SEC document
December 22, 2021 Filed Dec 27, 2021 21:31 UTC GrantStock Options (Right to Buy) · Derivative 2,550 $0.00 Strike: $12.18 $0.00
Disclosure

SEC source: 0001209191-21-071257 · doc4.xml · derivative · entry 2

Crowe Suzanne · CIK 0001816242 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,550

Underlying: Common Stock · 2,550 shares

Expires 2031-12-22

F4 · derivative.exercise_date: These Stock Options vest on the date 12 months following the grant date.

Read SEC document
December 22, 2021 Filed Dec 27, 2021 21:31 UTC GrantCommon Stock 4,350 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-071257 · doc4.xml · nonDerivative · entry 1

Crowe Suzanne · CIK 0001816242 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,462

F1 · price: Represents an award of Restricted Stock Units ("RSUs"), each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date.

F2 · balance_after: Includes 20,560 of the Issuer's CHESS Depositary Interests ("CDIs"). CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the "ASX") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of Common Stock and have all the rights and privileges of Common Stock. The Reporting Person's 20,560 CDIs translate into 4,112 of the shares of Common Stock set forth above.

F3 · balance_after: Includes unvested RSUs.

Read SEC document
December 22, 2021 Filed Dec 27, 2021 16:31 UTC GrantStock Options (Right to Buy) · Derivative 2,550 $0.00 Strike: $12.18 $0.00
Disclosure

SEC source: 0001209191-21-071254 · doc4.xml · derivative · entry 2

Drapeau Louis · CIK 0001816244 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,550

Underlying: Common Stock · 2,550 shares

Expires 2031-12-22

F4 · derivative.exercise_date: These Stock Options vest on the date 12 months following the grant date.

Read SEC document
December 22, 2021 Filed Dec 27, 2021 16:31 UTC GrantCommon Stock 4,350 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-071254 · doc4.xml · nonDerivative · entry 1

Drapeau Louis · CIK 0001816244 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,689

F1 · price: Represents an award of Restricted Stock Units ("RSUs"), each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date.

F2 · balance_after: Includes 1,695 of the Issuer's CHESS Depositary Interests ("CDIs"). CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the "ASX") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of Common Stock and have all the rights and privileges of Common Stock. The Reporting Person holds 1,695 CDIs, which translate into 339 of the shares of Common Stock set forth above

F3 · balance_after: Includes unvested RSUs.

Read SEC document
December 22, 2021 Filed Dec 27, 2021 16:31 UTC
Panaccio LouDirector
GrantStock Options (Right to Buy) · Derivative 2,550 $0.00 Strike: $12.18 $0.00
Disclosure

SEC source: 0001209191-21-071258 · doc4.xml · derivative · entry 3

Panaccio Lou · CIK 0001816237 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,550

Underlying: Common Stock · 2,550 shares

Expires 2031-12-22

F6 · derivative.exercise_date: These Stock Options vest on the date 12 months following the grant date.

Read SEC document
December 22, 2021 Filed Dec 27, 2021 16:31 UTC
Panaccio LouDirector
GrantCommon Stock 4,350 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-071258 · doc4.xml · nonDerivative · entry 1

Panaccio Lou · CIK 0001816237 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,442

F1 · price: Represents an award of Restricted Stock Units ("RSUs"), each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date.

F2 · balance_after: Includes 70,460 of the Issuer's CHESS Depositary Interests ("CDIs"). CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the "ASX") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of Common Stock and have all the rights and privileges of Common Stock. The Reporting Person holds 70,460 CDIs, which translate into 14,092 of the shares of Common Stock set forth above.

F3 · balance_after: Includes unvested RSUs.

Read SEC document
December 22, 2021 Filed Dec 27, 2021 16:30 UTC GrantStock Options (Right to Buy) · Derivative 2,550 $0.00 Strike: $12.18 $0.00
Disclosure

SEC source: 0001209191-21-071252 · doc4.xml · derivative · entry 4

CORBETT JAMES · CIK 0001238620 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,550

Underlying: Common Stock · 2,550 shares

Expires 2031-12-22

F5 · derivative.exercise_date: These Stock Options vest on the date 12 months following the grant date.

Read SEC document
December 22, 2021 Filed Dec 27, 2021 16:30 UTC GrantStock Options (Right to Buy) · Derivative 4,925 $0.00 Strike: $12.18 $0.00
Disclosure

SEC source: 0001209191-21-071252 · doc4.xml · derivative · entry 3

CORBETT JAMES · CIK 0001238620 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,925

Underlying: Common Stock · 4,925 shares

Expires 2031-12-22

F4 · derivative.exercise_date: These Stock Options vest in three equal annual installments on the first, second and third anniversaries of the grant date.

Read SEC document
December 22, 2021 Filed Dec 27, 2021 16:30 UTC GrantCommon Stock 4,350 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-071252 · doc4.xml · nonDerivative · entry 2

CORBETT JAMES · CIK 0001238620 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,025

F3 · price: Represents an award of RSUs that vest on the date 12 months following the grant date.

F2 · balance_after: Includes unvested RSUs.

Read SEC document
December 22, 2021 Filed Dec 27, 2021 16:30 UTC GrantCommon Stock 8,675 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-071252 · doc4.xml · nonDerivative · entry 1

CORBETT JAMES · CIK 0001238620 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,675

F1 · price: Represents an award of Restricted Stock Units ("RSUs"), each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs vest in three equal annual installments on the first, second and third anniversaries of the grant date.

F2 · balance_after: Includes unvested RSUs.

Read SEC document
December 22, 2021 Filed Dec 27, 2021 21:30 UTC GrantStock Options (Right to Buy) · Derivative 2,550 $0.00 Strike: $12.18 $0.00
Disclosure

SEC source: 0001209191-21-071255 · doc4.xml · derivative · entry 2

COOK JEREMY CURNOCK · CIK 0001216486 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,550

Underlying: Common Stock · 2,550 shares

Expires 2031-12-22

F3 · derivative.exercise_date: These Stock Options vest on the date 12 months following the grant date.

Read SEC document
December 22, 2021 Filed Dec 27, 2021 21:30 UTC GrantCommon Stock 4,350 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-071255 · doc4.xml · nonDerivative · entry 1

COOK JEREMY CURNOCK · CIK 0001216486 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,350

F1 · price: Represents an award of Restricted Stock Units ("RSUs"), each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date.

F2 · balance_after: Includes unvested RSUs.

Read SEC document
December 22, 2021 Filed Dec 27, 2021 21:30 UTC
PERRY MICHAEL SDirector · Chief Executive Officer
GrantStock Options (Right to Buy) · Derivative 13,800 $0.00 Strike: $12.18 $0.00
Disclosure

SEC source: 0001209191-21-071256 · doc4.xml · derivative · entry 6

PERRY MICHAEL S · CIK 0001250379 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,800

Underlying: Common Stock · 13,800 shares

Expires 2031-12-22

F9 · derivative.exercise_date: The vesting of these Stock Options is conditioned on the market capitalizaton of the Issuer being $1.25 billion or greater for 30 consecutive calendar days on or before December 31, 2024. Upon the condition being met, a portion of the Stock Options will vest immediately and the remainder will vest in a number of annual installments depending on the year in which the condition is met.

Read SEC document
December 22, 2021 Filed Dec 27, 2021 21:30 UTC
PERRY MICHAEL SDirector · Chief Executive Officer
GrantStock Options (Right to Buy) · Derivative 13,800 $0.00 Strike: $12.18 $0.00
Disclosure

SEC source: 0001209191-21-071256 · doc4.xml · derivative · entry 5

PERRY MICHAEL S · CIK 0001250379 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,800

Underlying: Common Stock · 13,800 shares

Expires 2031-12-22

F8 · derivative.exercise_date: These vesting of these Stock Options is conditioned on on the market price of the Issuer's Common Stock reaching $24.36 (based upon a 10-day volume-weighted average price) by June 30, 2023. Upon the condition being met, a portion of the Stock Options will vest immediately and the remainder will vest in a number of annual installments depending on the year in which the condition is met.

Read SEC document
December 22, 2021 Filed Dec 27, 2021 21:30 UTC
PERRY MICHAEL SDirector · Chief Executive Officer
GrantStock Options (Right to Buy) · Derivative 13,800 $0.00 Strike: $12.18 $0.00
Disclosure

SEC source: 0001209191-21-071256 · doc4.xml · derivative · entry 4

PERRY MICHAEL S · CIK 0001250379 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,800

Underlying: Common Stock · 13,800 shares

Expires 2031-12-22

F7 · derivative.exercise_date: These Stock Options vest in four equal annual installments on December 14, 2022, 2023, 2024 and 2025.

Read SEC document
December 22, 2021 Filed Dec 27, 2021 21:30 UTC
PERRY MICHAEL SDirector · Chief Executive Officer
GrantCommon Stock 23,820 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-071256 · doc4.xml · nonDerivative · entry 3

PERRY MICHAEL S · CIK 0001250379 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 302,811

F6 · price: Represents an award of RSUs with vesting conditioned on the market capitalizaton of the Issuer being $1.25 billion or greater for 30 consecutive calendar days on or before December 31, 2024. Upon the condition being met, a portion of the RSUs will vest immediately and the remainder will vest in a number of annual installments depending on the year in which the condition is met.

F2 · balance_after: Includes unvested RSUs.

F3 · balance_after: Includes 634,602 of the Issuer's CHESS Depositary Interests ("CDIs"). CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the "ASX") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of Common Stock and have all the rights and privileges of Common Stock. The Reporting Person holds 634,602 CDIs, which translate into 126,920 of the shares of Common Stock set forth above.

Read SEC document
December 22, 2021 Filed Dec 27, 2021 21:30 UTC
PERRY MICHAEL SDirector · Chief Executive Officer
GrantCommon Stock 23,820 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-071256 · doc4.xml · nonDerivative · entry 2

PERRY MICHAEL S · CIK 0001250379 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 278,991

F5 · price: Represents an award of RSUs with vesting conditioned on the market price of the Issuer's Common Stock reaching $24.36 (based upon a 10-day volume-weighted average price) by June 30, 2023. Upon the condition being met, a portion of the RSUs will vest immediately and the remainder will vest in a number of annual installments depending on the year in which the condition is met.

F2 · balance_after: Includes unvested RSUs.

F3 · balance_after: Includes 634,602 of the Issuer's CHESS Depositary Interests ("CDIs"). CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the "ASX") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of Common Stock and have all the rights and privileges of Common Stock. The Reporting Person holds 634,602 CDIs, which translate into 126,920 of the shares of Common Stock set forth above.

Read SEC document
December 22, 2021 Filed Dec 27, 2021 21:30 UTC
PERRY MICHAEL SDirector · Chief Executive Officer
GrantCommon Stock 23,800 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-071256 · doc4.xml · nonDerivative · entry 1

PERRY MICHAEL S · CIK 0001250379 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 255,171

F1 · price: Represents an award of Restricted Stock Units ("RSUs"), each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs vest in four equal annual installments on December 14, 2022, 2023, 2024 and 2025.

F2 · balance_after: Includes unvested RSUs.

F3 · balance_after: Includes 634,602 of the Issuer's CHESS Depositary Interests ("CDIs"). CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the "ASX") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of Common Stock and have all the rights and privileges of Common Stock. The Reporting Person holds 634,602 CDIs, which translate into 126,920 of the shares of Common Stock set forth above.

F4 · balance_after: Amount in column 5 reflects a decrease of 6,267 shares of Common Stock from the total reported in the Reporting Person's Form 4 filed on September 7, 2021 (the "Prior Form 4") following the finalization of a division of property with the Reporting Person's former spouse pursuant to a property settlement agreement. The Reporting Person no longer reports as beneficially owned any securities owned by his former spouse following a separation occurring after the Prior Form 4.

Read SEC document
September 20, 2021 Filed Sep 21, 2021 20:30 UTC PurchaseCommon Stock 1,066 $17.08 $18,207.28
Disclosure

SEC source: 0001209191-21-057037 · doc4.xml · nonDerivative · entry 1

Crowe Suzanne · CIK 0001816242 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,112

F1 · shares: Reflects 5,330 of the Issuer's CHESS Depositary Interests ("CDIs"). CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the "ASX") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of the Issuer's common stock and have all the rights and privileges of common stock.

F2 · price: The purchase price was converted from A$4.72, using the exchange rate as in effect on the date of the transaction, and reflects the 5:1 consolidation ratio applied in converting CDIs to shares of the Issuer's common stock.

F3 · balance_after: The Reporting Person holds 20,560 CDIs, which translate into the 4,112 shares of common stock set forth above.

Read SEC document
September 01, 2021 Filed Sep 7, 2021 20:05 UTC
PERRY MICHAEL SDirector · Chief Executive Officer
SaleCommon Stock 11,220 $20.68 $232,029.60
Disclosure

SEC source: 0001209191-21-054958 · doc4.xml · nonDerivative · entry 2

PERRY MICHAEL S · CIK 0001250379 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 237,638

F4 · kind: Represents shares sold in order to pay withholding taxes due in connection with the vesting of RSUs.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.36 to $20.82. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of the shares of Common Stock sold at each separate price within the ranges set forth in this footnote to this Form 4.

F2 · balance_after: Includes 634,602 of the Issuer's CHESS Depositary Interests ("CDIs"). CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the "ASX") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of Common Stock and have all the rights and privileges of Common Stock. The Reporting Person holds 634,602 CDIs, which translate into 126,920 of the shares of Common Stock set forth above.

F3 · balance_after: Includes 47,507 unvested RSUs, each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs were originally rights to receive ordinary shares of AVITA Medical, Ltd., an Australian public company and predecessor to the Issuer ("Predecessor"). Pursuant to a scheme of arrangement, completed on June 30, 2020, such RSUs became rights to be issued shares of Common Stock of the Issuer in the ratio of one share of Common Stock for every 100 ordinary shares of Predecessor to which the holder would otherwise have been entitled. The RSUs vest on June 1, 2022.

Read SEC document
September 01, 2021 Filed Sep 7, 2021 20:05 UTC
PERRY MICHAEL SDirector · Chief Executive Officer
GrantCommon Stock 23,754 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-054958 · doc4.xml · nonDerivative · entry 1

PERRY MICHAEL S · CIK 0001250379 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 248,858

F1 · kind: These shares of Common Stock were issued in connection with the vesting of Restricted Stock Units ("RSUs"), which were originally granted on November 26, 2019, upon the satisfaction of a performance-based vesting condition.

F2 · balance_after: Includes 634,602 of the Issuer's CHESS Depositary Interests ("CDIs"). CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the "ASX") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of Common Stock and have all the rights and privileges of Common Stock. The Reporting Person holds 634,602 CDIs, which translate into 126,920 of the shares of Common Stock set forth above.

F3 · balance_after: Includes 47,507 unvested RSUs, each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs were originally rights to receive ordinary shares of AVITA Medical, Ltd., an Australian public company and predecessor to the Issuer ("Predecessor"). Pursuant to a scheme of arrangement, completed on June 30, 2020, such RSUs became rights to be issued shares of Common Stock of the Issuer in the ratio of one share of Common Stock for every 100 ordinary shares of Predecessor to which the holder would otherwise have been entitled. The RSUs vest on June 1, 2022.

Read SEC document
July 06, 2021 Filed Sep 7, 2021 16:05 UTC
Quick AndrewChief Technology Officer
GrantStock Options (Right to Buy) · Derivative 6,925 $0.00 Strike: $20.21 $0.00
Disclosure

SEC source: 0001209191-21-054954 · doc4.xml · derivative · entry 3

Quick Andrew · CIK 0001817682 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,925

Underlying: Common Stock · 6,925 shares

Expires 2031-07-06

F3 · derivative.exercise_date: These Stock Options vest in four equal annual installments upon the satisfaction of certain performance-based vesting criteria with respect to the particular portion of such Stock Options.

Read SEC document
July 06, 2021 Filed Sep 7, 2021 16:05 UTC
Quick AndrewChief Technology Officer
GrantCommon Stock 10,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-054954 · doc4.xml · nonDerivative · entry 1

Quick Andrew · CIK 0001817682 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,500

F1 · price: Reflects Restricted Stock Units, each representing a contingent right to be issued one share of Common Stock. These Restricted Stock Units vest in four equal annual installments upon the satisfaction of certain performance-vesting criteria with respect to the particular portion of Restricted Stock Units.

Read SEC document
July 06, 2021 Filed Sep 7, 2021 16:05 UTC
Liberto ErinChief Commercial Officer
GrantStock Options (Right to Buy) · Derivative 6,925 $0.00 Strike: $20.21 $0.00
Disclosure

SEC source: 0001209191-21-054953 · doc4.xml · derivative · entry 3

Liberto Erin · CIK 0001816245 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,925

Underlying: Common Stock · 6,925 shares

Expires 2031-07-06

F3 · derivative.exercise_date: These Stock Options vest in four equal annual installments upon the satisfaction of certain performance-based vesting criteria with respect to the particular portion of such Stock Options.

Read SEC document
July 06, 2021 Filed Sep 7, 2021 16:05 UTC
Liberto ErinChief Commercial Officer
GrantCommon Stock 10,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-054953 · doc4.xml · nonDerivative · entry 1

Liberto Erin · CIK 0001816245 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,500

F1 · price: Reflects Restricted Stock Units, each representing a contingent right to be issued one share of Common Stock. These Restricted Stock Units vest in four equal annual installments upon the satisfaction of certain performance-vesting criteria with respect to the particular portion of Restricted Stock Units.

Read SEC document
July 06, 2021 Filed Sep 7, 2021 16:05 UTC
Shiroma DonnaGeneral Counsel
GrantStock Options (Right to Buy) · Derivative 6,925 $0.00 Strike: $20.21 $0.00
Disclosure

SEC source: 0001209191-21-054957 · doc4.xml · derivative · entry 3

Shiroma Donna · CIK 0001816251 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,925

Underlying: Common Stock · 6,925 shares

Expires 2031-07-06

F3 · derivative.exercise_date: These Stock Options vest in four equal annual installments upon the satisfaction of certain performance-based vesting criteria with respect to the particular portion of such Stock Options.

Read SEC document
July 06, 2021 Filed Sep 7, 2021 16:05 UTC
Shiroma DonnaGeneral Counsel
GrantCommon Stock 10,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-054957 · doc4.xml · nonDerivative · entry 1

Shiroma Donna · CIK 0001816251 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000

F1 · price: Reflects Restricted Stock Units, each representing a contingent right to be issued one share of Common Stock. These Restricted Stock Units vest in four equal annual installments upon the satisfaction of certain performance-based vesting criteria with respect to the particular portion of Restricted Stock Units.

Read SEC document
July 06, 2021 Filed Sep 7, 2021 20:05 UTC
Holder MichaelChief Financial Officer
GrantStock Options (Right to Buy) · Derivative 6,925 $0.00 Strike: $20.21 $0.00
Disclosure

SEC source: 0001209191-21-054959 · doc4.xml · derivative · entry 2

Holder Michael · CIK 0001515140 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,925

Underlying: Common Stock · 6,925 shares

Expires 2031-07-06

F3 · derivative.exercise_date: These Stock Options vest in four equal annual installments upon the satisfaction of certain performance-based vesting criteria with respect to the particular portion of such Stock Options.

Read SEC document
July 06, 2021 Filed Sep 7, 2021 20:05 UTC
Holder MichaelChief Financial Officer
GrantCommon Stock 10,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-054959 · doc4.xml · nonDerivative · entry 1

Holder Michael · CIK 0001515140 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,500

F1 · price: Reflects Restricted Stock Units, each representing a contingent right to be issued one share of Common Stock. These Restricted Stock Units vest in four equal annual installments upon the satisfaction of certain performance-based vesting criteria with respect to the particular portion of Restricted Stock Units.

F2 · balance_after: Includes unvested Restricted Stock Units.

Read SEC document
July 06, 2021 Filed Sep 7, 2021 20:05 UTC
McGee Kathy M.Chief Operating Officer
GrantStock Options (Right to Buy) · Derivative 6,925 $0.00 Strike: $20.21 $0.00
Disclosure

SEC source: 0001209191-21-054956 · doc4.xml · derivative · entry 2

McGee Kathy M. · CIK 0001835186 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,925

Underlying: Common Stock · 6,925 shares

Expires 2031-07-06

F2 · derivative.exercise_date: These Stock Options vest in four equal annual installments upon the satisfaction of certain performance-based vesting criteria with respect to the particular portion of such Stock Options.

Read SEC document
July 06, 2021 Filed Sep 7, 2021 20:05 UTC
McGee Kathy M.Chief Operating Officer
GrantCommon Stock 10,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-054956 · doc4.xml · nonDerivative · entry 1

McGee Kathy M. · CIK 0001835186 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,500

F1 · price: Reflects Restricted Stock Units, each representing a contingent right to be issued one share of Common Stock. These Restricted Stock Units vest in four equal annual installments upon the satisfaction of certain performance-vesting criteria with respect to the particular portion of Restricted Stock Units.

Read SEC document
July 06, 2021 Filed Jul 6, 2022 18:52 UTC Amendment
Shiroma DonnaGeneral Counsel
GrantCommon Stock 10,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-041372 · doc4a.xml · nonDerivative · entry 1

Shiroma Donna · CIK 0001816251 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,500

F1 · price: Reflects Restricted Stock Units, each representing a contingent right to be issued one share of Common Stock. These Restricted Stock Units vest in four equal annual installments upon the satisfaction of certain performance-based vesting criteria with respect to the particular portion of Restricted Stock Units.

F2 · balance_after: This Form 4/A is being filed solely to correct an administrative error in the number of shares of Common Stock shown as beneficially held by the Reporting Person in her Form 4 filed on September 7, 2021 (the "Original Form 4"). All other information set forth in the Original Form 4 remains correct.

Read SEC document
June 02, 2021 Filed Jun 4, 2021 20:06 UTC
PERRY MICHAEL SDirector · Chief Executive Officer
SaleCommon Stock 23,000 $17.33 $398,590.00
Disclosure

SEC source: 0001209191-21-038189 · doc4.xml · nonDerivative · entry 1

PERRY MICHAEL S · CIK 0001250379 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 225,104

F1 · kind: Represents shares sold in order to pay withholding taxes due in connection with the vesting of Restricted Stock Units ("RSUs").

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.11 to $17.73. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of the shares of Common Stock sold at each separate price within the ranges set forth in this footnote to this Form 4.

F3 · balance_after: Includes 634,602 of the Issuer's CHESS Depositary Interests ("CDIs"). CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the "ASX") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of Common Stock and have all the rights and privileges of Common Stock. The Reporting Person holds 634,602 CDIs, which translate into 126,920 of the shares of Common Stock set forth above.

F4 · balance_after: Includes 47,507 unvested RSUs, each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs were originally rights to receive ordinary shares of AVITA Medical, Ltd., an Australian public company and predecessor to the Issuer ("Predecessor"). Pursuant to a scheme of arrangement, completed on June 30, 2020, the RSUs became rights to be issued shares of Common Stock of the Issuer in the ratio of one share of Common Stock for every 100 ordinary shares of Predecessor to which the holder would otherwise have been entitled. The RSUs vest on June 1, 2022.

F5 · balance_after: 631,525 CDIs, which translate into 126,305 shares of Common Stock, and 50,677 shares of Common Stock were previously transferred to the Reporting Person's former spouse pursuant to a property settlement agreement entered into in connection with a divorce proceeding. The Reporting Person no longer reports as beneficially owned any securities owned by his former spouse.

Read SEC document
May 18, 2021 Filed Sep 7, 2021 16:05 UTC
Quick AndrewChief Technology Officer
GrantStock Options (Right to Buy) · Derivative 4,037 $0.00 Strike: $6.32 $0.00
Disclosure

SEC source: 0001209191-21-054954 · doc4.xml · derivative · entry 2

Quick Andrew · CIK 0001817682 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,187

Underlying: Common Stock · 4,037 shares

Expires 2027-05-18

F2 · derivative.exercise_date: These Stock Options were originally granted on May 18, 2017 and vested on May 18, 2021, upon the satisfaction of a performance-based vesting condition.

Read SEC document
May 18, 2021 Filed Sep 7, 2021 16:05 UTC
Liberto ErinChief Commercial Officer
GrantStock Options (Right to Buy) · Derivative 6,000 $0.00 Strike: $5.03 $0.00
Disclosure

SEC source: 0001209191-21-054953 · doc4.xml · derivative · entry 2

Liberto Erin · CIK 0001816245 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 6,000 shares

Expires 2027-09-06

F2 · derivative.exercise_date: These Stock Options were originally granted on September 6, 2017 and vested on May 18, 2021, upon the satisfaction of a performance-based vesting condition.

Read SEC document
May 18, 2021 Filed Sep 7, 2021 16:05 UTC
Shiroma DonnaGeneral Counsel
GrantStock Options (Right to Buy) · Derivative 4,400 $0.00 Strike: $4.38 $0.00
Disclosure

SEC source: 0001209191-21-054957 · doc4.xml · derivative · entry 2

Shiroma Donna · CIK 0001816251 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,000

Underlying: Common Stock · 4,400 shares

Expires 2028-06-25

F2 · derivative.exercise_date: These Stock Options were originally granted on June 25, 2018 and vested on May 18, 2021, upon the satisfaction of a performance-based vesting condition.

Read SEC document
May 11, 2021 Filed May 12, 2021 01:52 UTC
Holder MichaelChief Financial Officer
GrantStock Options (Right to Buy) · Derivative 112,500 $0.00 Strike: $19.91 $0.00
Disclosure

SEC source: 0001209191-21-031924 · doc4.xml · derivative · entry 1

Holder Michael · CIK 0001515140 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 112,500

Underlying: Common Stock · 112,500 shares

Expires 2031-05-11

F1 · derivative.exercise_date: These Stock Options vest based on performance-based vesting criteria.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.